Every day, researchers are working to get a better understanding of celiac disease and its various presentations. Ongoing research is also exploring potential drug treatments for celiac disease. To view all information related to drug development and research, please visit our main celiac disease research page. Learn about the Beyond Celiac Science Department here.
While oats are safe for most people with celiac disease, some patients react to the protein in oats with acute symptoms and a wheat-like inflammatory response, a study presented at Digestive Disease Week (DDW) found.
Three companies developing celiac disease drugs gave updates on their treatments recently at Digestive Disease Week (DDW).
Children who were diagnosed with celiac disease as part of a mass screening program had improved symptoms, quality of life and iron levels one year later, according to research presented at Digestive Disease Week (DDW).
Frustration and distress about symptoms lead most people with celiac disease to seek a diagnosis, according to a poster presented by Beyond Celiac at Digestive Disease Week.
The incidence rate of celiac disease has increased over the past two decades, largely driven by diagnosis of children from six to ten years old, according to a study based on Minnesota electronic health records and presented at Digestive Disease Week.
Beyond Celiac to present two original research projects at Digestive Disease Week this May
Children and adults with celiac disease have an increased risk of autoimmune arthritis and early diagnosis is important for effective treatment
The study is looking adults with celiac disease who are having problems controlling their celiac disease symptoms
Despite being less likely to be overweight, have high blood pressure or high cholesterol and other known risk factors, people who have celiac disease may be more likely to develop heart disease than people who don’t, according to a new UK study.
In children on the gluten-free diet who had no symptoms but whose celiac disease blood tests and biopsies showed active celiac disease a cow's milk protein allergy might be to blame, researchers at the University of Chicago Celiac Disease report in the findings from four case studies.
As we approach the end of 2022, we are reflecting on the significant strides made this year toward finding treatments and a cure for celiac disease
Genetic tests can reveal more than a simple “yes” or “no” regarding whether an at-risk child has the genes associated with celiac disease.
Two drugs currently under study for the treatment of celiac disease are part of new collaborations between pharmaceutical companies which could result in acceleration of the drugs’ progress.
A wide-spread screening study estimates that nearly 1.5 percent of the residents of one Norwegian county have celiac disease, and before the screening, 75 percent didn’t realize it
The vaccine for rotavirus does not increase or decrease the risk that a child will develop celiac disease, according to a new study from researchers at the University of Michigan.
Even on a gluten-free diet, more than half of those with celiac disease continue to have symptoms, often the same ones that led to diagnosis.
Celiac disease researchers' personal connection to the condition could have benefits for those who participate in celiac disease clinical trials, a study from Digestive Disease week suggests.
In a new registry of celiac disease patients at the University of Alabama at Birmingham, Black people with biopsy confirmed celiac disease were more likely than non-Hispanic whites to had have negative results on the most commonly used diagnostic blood test.
The Phase 3 clinical trial investigating larazotide acetate as a treatment for celiac disease was discontinued today by 9 Meters Biopharma, Inc.
It can be hard to imagine the specific place you would have your study visits and the study team you would interact with. To provide a more complete picture of clinical trial participation, we met with Dr. Amelie Therrien, a gastroenterologist at Beth Israel Deaconess Medical Center (BIDMC) in Boston, MA.
A drug designed to break gluten into harmless fragments successfully protected against damage of the small intestine in celiac disease patients, according to results of a study presented recently at Digestive Disease Week (DDW).
Beyond Celiac, NMQF study to examine and address health inequities in the diagnosis and treatment of celiac disease presented at largest global gathering of gastroenterologists
Early results of ACeD study (Assessment of KAN-101 in Celiac Disease), show that KAN-101 induced T-cell tolerance of gliadin, the harmful component of gluten, in study participants after they were given a gluten challenge.
You aren't alone if you feel like gluten exposure makes you feel sicker ever since your celiac disease diagnosis.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to
